Veracyte (VCYT) Misses Q3 EPS by 2c

Veracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $9.67 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Activist Corvex seeks Whitbread board seat over strategy concerns
• H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)